Belpointe Asset Management LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 79 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
Belpointe Asset Management LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2,239
+85.8%
1,0660.0%0.00%
Q4 2022$1,205
-99.0%
1,066
-96.4%
0.00%
-100.0%
Q2 2019$121,000
-12.3%
29,228
+8.3%
0.02%
-11.1%
Q1 2019$138,000
-26.2%
26,998
-13.3%
0.03%
-10.0%
Q3 2018$187,000
-32.5%
31,129
-28.5%
0.03%
-61.0%
Q2 2018$277,00043,5560.08%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders